Delivery Order SPE2DB20D2002-SPE2DB25FL77H
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $2,437.52 to AmerisourceBergen Drug Corp on September 18, 2025, for the supply of OxyContin ER 10 mg tablets (100-count units). The contract is classified as a firm fixed-price delivery order with no set-aside designation, indicating it was competitively awarded. The awardee, headquartered in Conshohocken, Pennsylvania, will perform the delivery at its corporate office location, with an ultimate completion date of September 19,...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on October 28, 2025, for the supply of OxyContin ER 40 mg tablets (100-count packages) valued at $1,322.76. This competitively awarded, non-set-aside contract represents a firm fixed-price delivery order with an ultimate completion date of October 29, 2025. The order is performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, and constitutes a child contract under the company's...
- The Defense Logistics Agency awarded a $2,873.08 firm fixed-price delivery order to AmerisourceBergen Drug Corp on October 20, 2025, for OxyContin ER 40 mg tablets (100-count unit). The contract, which was competitively awarded with no set-aside designation, has an ultimate completion date of October 21, 2025, and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. This delivery order represents a child contract under AmerisourceBergen's larger...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 14, 2025, for the supply of OxyContin ER 20 mg tablets (100-count) with a ceiling value of $2,320.18. This is a firm fixed-price delivery order with no set-aside designation, indicating the award was made through open competition. The contract is scheduled for ultimate completion on August 15, 2025, and performance will take place at AmerisourceBergen's corporate office in Conshohocken, Pennsylvania....
- The U.S. Defense Logistics Agency, through its Medical Supply Chain, awarded a delivery order to AmerisourceBergen Drug Corp on September 23, 2025, for the supply of OxyContin ER 80 mg tablets (100-count units) valued at $1,796.20. This is a firm fixed-price delivery order with an ultimate completion date of September 24, 2025, representing a single-transaction purchase of pharmaceutical inventory. The contract was competitively awarded without set-aside designation, leveraging...
- The Defense Logistics Agency (DLA) awarded AmerisourceBergen Drug Corp a delivery order valued at $4,916.57 on September 25, 2025, for the supply of OxyContin ER 20 mg tablets in quantities of 100. This is a firm fixed-price delivery order with no set-aside designation, issued under competitive procedures. The contractor's place of performance is located in Conshohocken, Pennsylvania, with an ultimate completion date of September 26, 2025. This delivery order is issued under AmerisourceBergen...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $3,845.42 on August 5, 2025, for the supply of OxyContin ER 20 mg tablets (100-count units). This is a firm fixed-price, non-set-aside contract with a completion date of August 6, 2025, and performance at AmerisourceBergen's facility in Conshohocken, Pennsylvania. The delivery order was issued as a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on November 12, 2025, for the supply of OxyContin ER 20 mg tablets (100 count) with a ceiling value of $1,842.35. This competitively awarded, firm fixed-price delivery order is scheduled for completion by November 13, 2025, and will be performed at AmerisourceBergen's corporate headquarters in Conshohocken, Pennsylvania. The contract contains no set-aside designation and represents a continuation of...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on November 6, 2025, for the supply of OxyContin ER 20 mg tablets in quantities of 100 units, with a ceiling value of $3,215.89. This is a firm fixed price, competitively awarded delivery order with no set-aside designation. The contract is scheduled for ultimate completion on November 7, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. As a critical...
- The U.S. Defense Logistics Agency (DLA) awarded a firm-fixed-price delivery order contract worth $6,319.02 to AmerisourceBergen Drug Corporation's Corporate Office division. The contract is for the supply of 4,565,735 units of OxyContin ER 40 mg tablets, with a period of performance through September 10, 2024. This delivery order is part of a larger Indefinite Delivery Contract (IDC) between AmerisourceBergen and DLA Troop Support Medical, valued at up to $999,999,999 and running through...
- SPE2DB20D2002Indefinite Delivery Contract
- SPE2DB20D2002-SPE2DB25FL77HDelivery Order
The Defense Logistics Agency (DLA) awarded AmerisourceBergen Drug Corp a $2,370.38 delivery order contract on September 18, 2025, for the supply of OxyContin ER 20 mg tablets (100-count units). The contract is structured as a firm fixed-price delivery order with a completion date of September 19, 2025, and represents a non-set-aside competitive award. The awardee will perform the work at its corporate office location in Conshohocken, Pennsylvania. This delivery order is a child contract issued under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999 and extending through December 2026. As a primary pharmaceutical distributor for federal medical procurement, AmerisourceBergen Drug Corp supplies critical pharmaceutical products and medical commodities to support military healthcare systems, the Defense Health Agency, U.S. Coast Guard, and other government healthcare entities. The company's extensive federal contract portfolio demonstrates its capability to fulfill diverse medical supply requirements across multiple therapeutic domains through competitive federal procurement processes.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $2.4k | 9/18/25 |